Abstract
Hepcidin Suppression By Momelotinib Is Associated with Increased Iron Availability and Erythropoiesis in Transfusion-Dependent Myelofibrosis Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have